Paolo Ghia
San Raffaele Hospital · IRCCS San Raffaele · OSPEDALE S. RAFFAELE - MILANO
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Paolo Ghia as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:54 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04754035 · Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaPaolo Ghia · unknown · Chronic Lymphocytic Leukemia · study chair
- N/ANCT04370457 · MyPal ePRO-based Early Palliative Care System in Adult Patients With Hematologic MalignanciesCentre for Research and Technology Hellas · unknown · Chronic Lymphocytic Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph3NCT03836261 · Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLLAcerta Pharma BV · active not recruiting · Chronic Lymphocytic Leukemia · principal investigator
- Ph2NCT01681563 · Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic LeukemiaNiguarda Hospital · completed · Chronic Lymphocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:54 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:54 UTC. The ranking covers the 200 most relevant of 54 PubMed records, and a shared surname and initials can bring in a namesake. All 54 on PubMed
- Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.N Engl J Med · 20141,390 citationsRCR 36.7
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.N Engl J Med · 20151,350 citationsRCR 39.6
- Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.N Engl J Med · 2016763 citationsRCR 23.8
- Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.J Clin Oncol · 2021589 citationsRCR 33.6
- 569 citationsRCR 18.4
- 563 citationsRCR 23.2
- 404 citationsRCR 17.1
- Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.Lancet · 2021399 citationsRCR 21.4
- 320 citationsRCR 12.8
- 299 citationsRCR 9.2